Georgiev M, Krivoshiev S, Kraev Z
Khirurgiia (Sofiia). 1989;42(6):87-8.
With the present study the authors set themselves the task to compare the number of peritonitis episodes in patients treated with two types of systems: "Sorin-Biomedica" and "Travenol-(UV-XD)", in which disinfection of the connecting devices is achieved accordingly with chemical agents and with ultraviolet irradiation. Eleven patients have been observed from August 1984 through February 1989. The total duration of treatment was 156 months. Twenty one peritonitis episodes were observed--15 with "Sorin-Biomedica" system and 6 with "Travenol-(UV-XD)" system--an average of one episode in 4 1/2 months with the former system and one episode in 14.7 months with the latter. It is pointed out in conclusion that the "Travenol-(UV-XD)" system with ultraviolet disinfection has significantly reduced the incidence of peritonitis at the dialysis center where the authors work.
在本研究中，作者给自己设定了一项任务，即比较使用两种系统治疗的患者的腹膜炎发作次数：“索林生物医学公司（Sorin-Biomedica）”系统和“特拉文诺尔（Travenol）-（UV-XD）”系统，其中连接装置的消毒分别通过化学试剂和紫外线照射来实现。从1984年8月至1989年2月观察了11名患者。治疗总时长为156个月。观察到21次腹膜炎发作——使用“索林生物医学公司”系统的有15次，使用“特拉文诺尔-（UV-XD）”系统的有6次——前者平均每4个半月发作一次，后者平均每14.7个月发作一次。结论指出，在作者工作的透析中心，采用紫外线消毒的“特拉文诺尔-（UV-XD）”系统显著降低了腹膜炎的发生率。
